000 01221 a2200349 4500
005 20250513122753.0
264 0 _c19970825
008 199708s 0 0 eng d
022 _a0360-3016
024 7 _a10.1016/s0360-3016(97)00100-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLattanzi, J P
245 0 0 _aEarly stage prostate cancer treated with radiation therapy: stratifying an intermediate risk group.
_h[electronic resource]
260 _bInternational journal of radiation oncology, biology, physics
_cJun 1997
300 _a569-73 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aPatient Selection
650 0 4 _aPrognosis
650 0 4 _aProstate-Specific Antigen
_xblood
650 0 4 _aProstatic Neoplasms
_xblood
650 0 4 _aRadiotherapy Dosage
700 1 _aHanlon, A L
700 1 _aHanks, G E
773 0 _tInternational journal of radiation oncology, biology, physics
_gvol. 38
_gno. 3
_gp. 569-73
856 4 0 _uhttps://doi.org/10.1016/s0360-3016(97)00100-4
_zAvailable from publisher's website
999 _c9211871
_d9211871